Zealand Pharma saw the highest growth of 0.99% in patent filings in April and 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Zealand Pharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Zealand Pharma has been focused on protecting inventions in United States(US) with eight publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 29% filings and 50% grants. The United States(US), Australia(AU), World Intellectual Property Organization(WIPO), and Israel(IL) patent Office are among the top ten patent offices where Zealand Pharma is filings its patents. Among the top granted patent authorities, Zealand Pharma has 50% of its grants in United States(US), 33% in Australia(AU) and 17% in Israel(IL).
Immatics and Roche could be the strongest competitors for Zealand Pharma
Patents related to rare diseases and climate change lead Zealand Pharma's portfolio
Zealand Pharma has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 80% of patents were filed and 100% of patents were granted in Q2 2024.
Obesity related patents lead Zealand Pharma portfolio followed by diabetes, and inflammation
Zealand Pharma has highest number of patents in obesity followed by diabetes, inflammation, short bowel syndrome, and inflammatory bowel disease. For obesity, nearly 11% of patents were filed and 5% of patents were granted in Q2 2024.
For comprehensive analysis of Zealand Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
